vildagliptin/metformin rivopharm 50 mg/850 mg filmtabletta
holsten pharma gmbh - a vildagliptin; metformin-hidroklorid -
vildagliptin/metformin rivopharm 50 mg/1000 mg filmtabletta
holsten pharma gmbh - a vildagliptin; metformin-hidroklorid -
vildagliptin/metformin supremex 50 mg/1000 mg filmtabletta
supremex kft. - a vildagliptin; metformin-hidroklorid -
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - a vildagliptin, metformin-hidroklorid - diabetes mellitus, 2. típus - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5. és 5. sz. 1 a rendelkezésre álló adatokra a különböző kombinációk esetén).
vildus 50 mg tabletta
win medica s.a. - vildagliptin -
anvildis 50 mg tabletta
vipharm s.a. - vildagliptin -
kwikaton 50 mg tabletta
stada arzneimittel ag - vildagliptin -
melkart 50 mg tabletta
g.l. pharma gmbh - vildagliptin -
jalra
novartis europharm limited - vildagliptin - diabetes mellitus, 2. típus - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5. és 5. sz. 1 a rendelkezésre álló adatokra a különböző kombinációk esetén).
galvus
novartis europharm limited - vildagliptin - diabetes mellitus, 2. típus - cukorbetegségben szedett gyógyszerek - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.